Results 121 to 130 of about 5,693 (231)

Exploring the Impact of Diabetes Mellitus on Clinical Outcomes in Patients Following Severe Traumatic Brain Injury Using the TriNetX Database

Surgeries
Introduction: Traumatic brain injury (TBI) involves a diverse group of head blunt and/or penetrating injuries and is a leading cause of death in the U.S., accounting for one-third of all injury-related deaths.
Kamal Shaik, Spencer Rasmussen, Rudy Rahme, Michael Karsy   +3 more
doaj   +1 more source

Comparison of cardiovascular outcomes between once‐weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2661-2671, April 2026.
Abstract Aims This study aims to compare the risk of major adverse cardiovascular events (MACE) among United States individuals with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) treated with once‐weekly semaglutide vs. dulaglutide.
Xi Tan, Yuanjie Liang, Lin Xie, Joanna Harton, Cynthia Gutierrez, Chalak Muhammad, Caroline Swift, Adam de Havenon   +7 more
wiley   +1 more source

Inpatient Outcomes of Atrial Fibrillation in Patients With Acute Pancreatitis: Insights From the TriNetX Database

Journal of Arrhythmia
Background Research regarding the adverse outcomes of atrial fibrillation (AF) in patients with acute pancreatitis (AP) is limited. We hypothesize that the presence of AF is associated with worse inpatient outcomes, including increased mortality and ...
Obaid Ur Rehman, Waqas Rasheed, Adeena Jamil, Eeshal Fatima, Tariq Jamal Siddiqi, Raheel Ahmed, Matthew G. D. Bates, Naser Yamani, Ahsan Alam, Jishanth Mattumpuram   +9 more
doaj   +1 more source

Risk of dyslipidemia and major adverse cardiac events with tofacitinib versus adalimumab in rheumatoid arthritis: a real-world cohort study from 7580 patients

Frontiers in Pharmacology
ObjectiveTo compare the effects of tofacitinib and adalimumab on the risk of adverse lipidaemia outcomes in patients with newly diagnosed rheumatoid arthritis (RA).MethodsData of adult patients newly diagnosed with RA who were treated with tofacitinib or
Xiao-Na Ma, Xiao-Na Ma, Mei-Feng Shi, Mei-Feng Shi, Shiow-Ing Wang, Shiow-Ing Wang, Wei Feng, Wei Feng, Shu-Lin Chen, Shu-Lin Chen, Xiao-Qin Zhong, Xiao-Qin Zhong, Qing-Ping Liu, Qing-Ping Liu, James Cheng-Chung Wei, James Cheng-Chung Wei, James Cheng-Chung Wei, James Cheng-Chung Wei, James Cheng-Chung Wei, Chang-Song Lin, Chang-Song Lin, Qiang Xu, Qiang Xu   +22 more
doaj   +1 more source

Dentition‐Cognition Relationship in Aging Populations: A Meta‐Analysis of Longitudinal Data

Journal of Oral Rehabilitation, Volume 53, Issue 4, Page 924-938, April 2026.
Tooth loss is a risk factor for cognitive impairment in longitudinal studies. The application of dentures can alleviate the side impact of tooth loss on cognitive decline. ABSTRACT Background Recent research suggests a potential link between tooth loss and cognitive decline among the elderly population, but longitudinal evidence remains limited.
Huimin Chen, Ling Ji, Yilin Wang, Iven Klineberg, Hui Chen   +4 more
wiley   +1 more source

Mortality Outcomes in Patients With Plaque Psoriasis and Hidradenitis Suppurativa: The Role of Biologic Therapy

Actas Dermo-Sifiliográficas
Background and objectives: Plaque psoriasis (Pso) and hidradenitis suppurativa (HS) are chronic inflammatory diseases associated with multiple comorbidities, including cardiovascular conditions, which may negatively impact survival. The aim of this study
R. Rivera-Díaz, B. Joven, A. Gotor-Rivera, J. Hernández   +3 more
doaj   +1 more source

Evaluation of the Risk of Psoriatic Arthritis in Patients With Psoriasis Undergoing Biological Treatment. Global Population Study (TRINETX)

Actas Dermo-Sifiliográficas
Introduction: Psoriatic arthritis (PsA) is an inflammatory condition associated with psoriasis (PsO), with variable prevalence ranging from 6% to 42%. Despite the known link between PsO and PsA, reliable biomarkers for predicting PsA onset remain elusive.
R. Rivera-Diaz, B. Joven, G. Hernandez-Ibarburu, C. García-Donoso, J.L. Pablos, P.L. Ortiz-Romero   +5 more
doaj   +1 more source

Cross-Sectional analysis of demographic and clinical characteristics of patients in the United States using icosapent ethyl. [PDF]

INTRODUCTION: Icosapent ethyl (IPE) is indicated for the treatment of severe hypertriglyceridemia (triglycerides ≥500 mg/dl) and for reducing the risk of cardiovascular (CV) events in statin-treated adults with moderately elevated triglycerides (150-499 ...
Abrahamson, David, Ganda, Om, Hannachi, Hakima, Hartman, Josh, Luciano, Sierra, Nelson, John, Philip, Sephy, Soran, Handrean, Toth, Peter, Wong, Nathan   +9 more
core   +1 more source

Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort [PDF]

INTRODUCTION: This analysis examined the baseline characteristics and clinical outcomes of patients with chronic kidney disease (CKD) and rapid or non-rapid estimated glomerular filtration rate (eGFR) decline, using retrospective data from DISCOVER CKD ...
Arnold, Matthew, Cabrera, Claudia, Carrero, Juan-Jesus, Chen, Hungta, Heerspink, Hiddo, Kanda, Eiichiro, Lainscak, Mitja, Lam, Carolyn SP, Nolan, Stephen, Pecoits-Filho, Roberto, Pollock, Carol, Sanchez, Juan Jose Garcia, Wheeler, David C, Wittbrodt, Eric   +13 more
core  

Comparative Mortality in Heart Failure on Guideline‐Directed Medical Therapy Versus Malignant Cancer: A Report From a Global Federated Research Network

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Guideline‐directed medical therapy (GDMT), including angiotensin receptor‐neprilysin inhibitor, angiotensin‐converting enzyme inhibitors, beta blockers, mineralocorticoid receptor antagonists, and sodium‐glucose cotransporter‐2 inhibitors, has
Luca Monzo, Guillaume Baudry, Kevin Duarte, Gema Hernandez, Olivier Denquin, Gianluigi Savarese, Nicolas Girerd   +6 more
doaj   +1 more source